BAP Pharma PL WP

News

Biogen receives EMA CHMP recommendation for ALS drug Qalsody

The decision on the marketing authorisation for Biogen Qalsody is expected in Q2 2024.

Phalguni Deswal

News

FDA cracks down on online retailers selling unapproved GLP-1 agonists

News

Aclaris chops workforce and shifts lead drug’s focus to cancer indications

Features

What’s in a name: Agencies struggle to keep up with expanding drug space

Sign up to the newsletter: In Brief

I would also like to subscribe to:

Pharma Technology Focus : Focus (monthly)

Thematic Take (monthly)

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close

Sections

Sections

Sections

Sections

Sections

Biogen receives EMA CHMP recommendation for ALS drug Qalsody

FDA cracks down on online retailers selling unapproved GLP-1 agonists

Aclaris chops workforce and shifts lead drug’s focus to cancer indications

What’s in a name: Agencies struggle to keep up with expanding drug space

Leading lead generation providers and technology solutions for the pharmaceutical industry

Leading sales enablement, prospecting and automation providers and technology solutions for the pharmaceutical industry

Sign up for our daily news round-up!

Sign up to the newsletter: In Brief